Kathera Bioscience
Manufacturing · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1000 Morris Ave Ste 5-13, Union, New Jer...Website
www.katherabio.comRevenue
<$5 MillionIndustry
About Kathera Bioscience
Kathera Bioscience Inc. is focused on developing novel antifungal therapies to address the rising global incidence of fungal infections, which pose significant health risks. The company aims to create broad-spectrum drugs that overcome the limitations of existing treatments, particularly in the face of drug-resistant fungi. With a team of industry experts and innovative technology, KatheraBio is dedicated to advancing drug discovery and development through collaboration and partnerships. Located in the Institute for Life Science Entrepreneurship in New Jersey, the company benefits from a supportive research environment that fosters scientific innovation.Explore more
Kathera Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Kathera Bioscience
Compare insights from companies similar to Kathera Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Kathera Bioscience
<$5M
1-10
Private
-
2020
JB
James BalkovecFounder & Vice President, Acting, Chemistry
Kathera Bioscience Tech Stack
A closer look at the technologies used by Kathera Bioscience
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kathera Bioscience
Sign Up For FreeTo access detailed company insights
Kathera Bioscience Inc. is focused on developing novel antifungal therapies to address the rising global incidence of fungal infections, which pose significant health risks. The company aims to create broad-spectrum drugs that overcome the limitations of existing treatments, particularly in the face of drug-resistant fungi. With a team of industry... Read More
